Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [11447]

Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with high-risk localised prostate cancer show 100% biochemical free recurrence rate more than two years post-surgery

Phase 2 data for apalutamide plus androgen deprivation therapy following radical prostatectomy in patients with...

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive bladder cancer

TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk non-muscle-invasive...

Dogma-challenging telomere findings may offer new insights for cancer treatments

Dogma-challenging telomere findings may offer new insights for cancer treatments

Study: You’re breathing potential carcinogens inside your car

Study: You’re breathing potential carcinogens inside your car

Road of no return — loss of TP53 paves a defined evolution path from gastric preneoplasia-to-cancer

Road of no return — loss of TP53 paves a defined evolution path from gastric preneoplasia-to-cancer

Intermittent fasting protects against liver inflammation and liver cancer

Intermittent fasting protects against liver inflammation and liver cancer

AI predicts tumour-killing cells with high accuracy

AI predicts tumour-killing cells with high accuracy

Study sheds light on cancer cell ‘tug-of-war’

Study sheds light on cancer cell ‘tug-of-war’

New PET agent provides exceptional same-day imaging for clear cell renal cell carcinoma patients

New PET agent provides exceptional same-day imaging for clear cell renal cell carcinoma patients

Researchers use foundation models to discover new cancer imaging biomarkers

Researchers use foundation models to discover new cancer imaging biomarkers

More from ecancer